Works matching DE "ARIPIPRAZOLE"
Results: 2174
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries.
- Published in:
- Epidemiology & Psychiatric Science, 2024, v. 33, p. 1, doi. 10.1017/S2045796024000040
- Publication type:
- Article
DEVELOPMENT OF A FAST, RELIABLE, ROBUST TANDEM MASS SPECTROMETRIC METHOD FOR DETERMINATION OF QUETIAPINE LEVELS.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
Association of Serum Trace Elements with Schizophrenia and Effects of Antipsychotic Treatment.
- Published in:
- Biological Trace Element Research, 2018, v. 181, n. 1, p. 22, doi. 10.1007/s12011-017-1039-6
- By:
- Publication type:
- Article
Combination of Omega-3 Fatty Acids, Lithium, and Aripiprazole Reduces Oxidative Stress in Brain of Mice with Mania.
- Published in:
- Biological Trace Element Research, 2014, v. 160, n. 3, p. 409, doi. 10.1007/s12011-014-0067-8
- By:
- Publication type:
- Article
Involvement of the TNF-α/SATB2 axis in the induced apoptosis and inhibited autophagy of osteoblasts by the antipsychotic Risperidone.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00466-9
- By:
- Publication type:
- Article
Salt bridge: key interaction between antipsychotics and receptors.
- Published in:
- Theoretical Chemistry Accounts: Theory, Computation, & Modeling, 2023, v. 142, n. 8, p. 1, doi. 10.1007/s00214-023-03016-6
- By:
- Publication type:
- Article
Multi-Site Evaluation of Immunoassays for Antipsychotic Drug Measurement in Clinical Samples.
- Published in:
- Journal of Applied Laboratory Medicine, 2021, v. 6, n. 6, p. 1541, doi. 10.1093/jalm/jfab062
- By:
- Publication type:
- Article
Challenges of treating catatonia in the community setting without access to electroconvulsive therapy.
- Published in:
- Medicine Access @ Point of Care, 2023, v. 7, p. 1, doi. 10.1177/27550834231220504
- By:
- Publication type:
- Article
Melatonin Use in Infants Admitted to Intensive Care Units.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2023, v. 28, n. 7, p. 635, doi. 10.5863/1551-6776-28.7.635
- By:
- Publication type:
- Article
Effect of a Delirium Screening Tool on Antipsychotic Medication Use in a Pediatric Intensive Care Unit.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2023, v. 28, n. 2, p. 156, doi. 10.5863/1551-6776-28.2.156
- By:
- Publication type:
- Article
Chlorpromazine as Treatment for Refractory Agitation Associated with Pediatric Delirium.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2022, v. 27, n. 8, p. 725, doi. 10.5863/1551-6776-27.8.725
- By:
- Publication type:
- Article
Low Dose of Abilify (Aripiprazole) in Combination With Effexor XR (Venlafaxine HCl) Resulted in Cessation of Lactation: A Case Report.
- Published in:
- Clinical Lactation, 2019, v. 10, n. 2, p. 56, doi. 10.1891/2158-0782.10.2.56
- By:
- Publication type:
- Article
Aripiprazole for autism spectrum disorders (ASD), a Cochrane Review.
- Published in:
- BJPsych Advances, 2023, v. 29, n. 5, p. 289, doi. 10.1192/bja.2023.15
- By:
- Publication type:
- Article
Aripiprazole in autism spectrum disorder: current evidence for use.
- Published in:
- BJPsych Advances, 2023, v. 29, n. 5, p. 290, doi. 10.1192/bja.2022.77
- By:
- Publication type:
- Article
Partial agonists of dopamine receptors: clinical effects and dopamine receptor interactions in combining aripiprazole with a full antagonist in treating psychosis.
- Published in:
- BJPsych Advances, 2023, v. 29, n. 2, p. 158, doi. 10.1192/bja.2022.86
- By:
- Publication type:
- Article
Partial agonists of dopamine receptors: mechanisms and clinical effects of aripiprazole, brexpiprazole and cariprazine.
- Published in:
- BJPsych Advances, 2023, v. 29, n. 2, p. 145, doi. 10.1192/bja.2021.49
- By:
- Publication type:
- Article
Management of antipsychotic-induced hyperprolactinaemia.
- Published in:
- BJPsych Advances, 2017, v. 23, n. 4, p. 278, doi. 10.1192/apt.bp.115.014928
- By:
- Publication type:
- Article
Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment.
- Published in:
- Hereditas, 2020, v. 157, n. 1, p. N.PAG, doi. 10.1186/s41065-020-00158-6
- By:
- Publication type:
- Article
PHARMACOTHERAPY OF CHALLENGING BEHAVIOURS IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER.
- Published in:
- Postepy Psychiatrii i Neurologii / Advances in Psychiatry & Neurology, 2019, v. 28, n. 2, p. 145, doi. 10.5114/ppn.2019.86257
- By:
- Publication type:
- Article
Evaluating the feasibility of a decision aid to promote shared decision making among young adults with first-episode psychosis: protocol for a pilot study.
- Published in:
- Pilot & Feasibility Studies, 2021, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40814-020-00757-0
- By:
- Publication type:
- Article
Evaluating the feasibility of a decision aid to promote shared decision making among young adults with first-episode psychosis: protocol for a pilot study.
- Published in:
- Pilot & Feasibility Studies, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40814-020-00757-0
- By:
- Publication type:
- Article
The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa.
- Published in:
- International Journal of Eating Disorders, 2017, v. 50, n. 4, p. 447, doi. 10.1002/eat.22704
- By:
- Publication type:
- Article
Aripiprazole, a partial dopamine agonist to improve adolescent anorexia nervosa-A case series.
- Published in:
- International Journal of Eating Disorders, 2016, v. 49, n. 5, p. 529, doi. 10.1002/eat.22485
- By:
- Publication type:
- Article
Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 3, p. 339, doi. 10.3390/healthcare12030339
- By:
- Publication type:
- Article
The Relationship between the Second-Generation Antipsychotics Efficacy and the Traditional Chinese Medicine Body Constitutions in Patients with Schizophrenia.
- Published in:
- Healthcare (2227-9032), 2021, v. 9, n. 11, p. 1480, doi. 10.3390/healthcare9111480
- By:
- Publication type:
- Article
Pharmacokinetics of Clozapine: An Investigate the Potential Molecular Mechanisms of Action.
- Published in:
- Journal of Chemical Health Risks, 2022, v. 12, n. 2, p. 247, doi. 10.22034/jchr.2021.1941063.1415
- By:
- Publication type:
- Article
Color Coding Assessment of Haloperidol Effects on Animal Behavior in the Open Field Test.
- Published in:
- Journal of Evolutionary Biochemistry & Physiology, 2023, v. 59, n. 1, p. 274, doi. 10.1134/S0022093023010222
- By:
- Publication type:
- Article
Use of Naïve Bayes Classifier to Assess the Effects of Antipsychotic Agents on Brain Electrical Activity Parameters in Rats.
- Published in:
- Journal of Evolutionary Biochemistry & Physiology, 2022, v. 58, n. 4, p. 1130, doi. 10.1134/S0022093022040160
- By:
- Publication type:
- Article
PP146 Cost Effectiveness Of Aripiprazole Orally Disintegrating Tablets For The Treatment Of Schizophrenia In China.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
PP170 Quantifying the Life-Cycle Value of Second Generation Antipsychotics.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
PD04 Cost-Utility Of Quetiapine For Schizophrenia: A Systematic Review.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Author Correction: Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Antipsychotic medication use and fracture: a case–control study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40762-w
- By:
- Publication type:
- Article
Experimental solubility of aripiprazole in supercritical carbon dioxide and modeling.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40537-3
- By:
- Publication type:
- Article
The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45783-z
- By:
- Publication type:
- Article
Antipsychotic medication use and fracture: a case–control study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40762-w
- By:
- Publication type:
- Article
Experimental solubility of aripiprazole in supercritical carbon dioxide and modeling.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40537-3
- By:
- Publication type:
- Article
Author Correction: Neuroimaging glutamatergic mechanisms differentiating antipsychotic treatment-response.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
PERFIL DE UTILIZAÇÃO DE MEDICAMENTOS PSICOTRÓPICOS DOS USUÁRIOS DO CENTRO DE ATENÇÃO PSICOSSOCIAL DE CUITÉ-PB.
- Published in:
- Periódico Tchê Química, 2019, v. 16, n. 32, p. 794
- By:
- Publication type:
- Article
BUDGET IMPACT ANALYSIS OF ANTIPSYCHOTIC DRUGS IN THE HOSPITAL TREATMENT OF SCHIZOPHRENIA.
- Published in:
- Periódico Tchê Química, 2019, v. 16, n. 32, p. 509, doi. 10.52571/ptq.v16.n32.2019.527_periodico32_pgs_509_515.pdf
- By:
- Publication type:
- Article
Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.
- Published in:
- 2018
- Publication type:
- Correction Notice
Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.
- Published in:
- Alcohol & Alcoholism, 2018, v. 53, n. 3, p. 268, doi. 10.1093/alcalc/agx108
- By:
- Publication type:
- Article
The effects of antipsychotic switching on diabetes in chronic schizophrenia.
- Published in:
- Diabetic Medicine, 2014, v. 31, n. 3, p. e16, doi. 10.1111/dme.12359
- By:
- Publication type:
- Article
The use of carbamazepine to expedite the metabolism of a long‐acting aripiprazole injection.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 4, p. 562, doi. 10.1111/jcpt.13563
- By:
- Publication type:
- Article
Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 1, p. 1, doi. 10.1111/jcpt.13034
- By:
- Publication type:
- Article
Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: A systematic review and meta‐analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2019, v. 44, n. 2, p. 163, doi. 10.1111/jcpt.12780
- By:
- Publication type:
- Article
Lack of a pharmacokinetic drug-drug interaction between lithium and valproate when co-administered with aripiprazole.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 5, p. 565, doi. 10.1111/j.1365-2710.2012.01331.x
- By:
- Publication type:
- Article
Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 3, p. 370, doi. 10.1111/j.1365-2710.2011.01290.x
- By:
- Publication type:
- Article
Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1389814
- By:
- Publication type:
- Article
Prediction of antipsychotics efficacy based on a polygenic risk score: a real-world cohort study.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1274442
- By:
- Publication type:
- Article